Coronary Spastic Angina in Patients with Connective Tissue Disease

Circulation Journal

Volumn 68, Issue 4, 2004, Pages 367-370

  Soejima, Hirofumi ^a,b   Miyamoto, Shinzo ^a   Kojima, Sunao ^a   Hokamaki, Jun ^a   Tanaka, Tomoko ^a   Kawano, Hiroaki ^a   Sugiyama, Seigo ^a   Sakamoto, Tomohiro ^a   Yoshimura, Michihiro ^a   Kishikawa, Hideki ^b   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Connective tissue disease; Inflammation; Vasospasm

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORONARY ARTERY SPASM; CORRELATION ANALYSIS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; STABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONNECTIVE TISSUE DISEASES; CORONARY VASOSPASM; FEMALE; HUMANS; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; T-LYMPHOCYTE SUBSETS;

EID: 11144357487     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.367     Document Type: Article

References (26)

1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 36: 115-126.
2. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-733.
3. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462-466.
4. Mutru O, Laakso M, Isomaki H, Koota K. Ten-year mortality and causes of death in patients with rheumatoid arthritis. BMJ 1985; 290: 1797-1799.
5. Prior P, Symmons DP, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984; 23: 92-99.
6. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995; 22: 1065-1067.
7. Ward MM. Hospital experience and mortality in patients with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 891-898.
8. Ward MM. Hospital experience and expected mortality in patients with systemic lupus erythematosus: A hospital level analysis. J Rheumatol 2000; 27: 2146-2151.
9. Soejima H, Irie A, Miyamoto S, Kajiwara I, Kojima S, Hokamaki J, et al. Preference toward a T-helper type 1 response in patients with coronary spastic angina. Circulation 2003; 107: 2196-2200.
10. Yasue H, Kugiyama K. Coronary spasm: Clinical features and pathogenesis. Intern Med 1997; 36: 760-765.
11. Murakami H, Hirokami M, Hanawa N, Oomoto Y, Yamaguchi Y, Miyamoto K, et al. Acetylcholine-induced coronary spasm with a history of Kawasaki disease: Case report. Circ J 2003; 67: 273-274.
12. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74: 955-963.
13. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988; 12: 883-888.
14. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
15. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 1876-1890.
16. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study. Am J Epidemiol 1997; 145: 408-415.
17. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-2745.
18. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999; 100: 2135-2139.
19. Nanki T, Imai T, Nagasaka K, Urasaki Y, Nonomura Y, Taniguchi K, et al. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 2878-2883.
20. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000; 9: 170-175.
21. Oldgren J, Wallentin L, Grip L, Linder R, Norgaard BL, Siegbahn A. Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease. Eur Heart J 2003; 24: 86-93.
22. Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001; 104: 992-997.
23. Ichihara Y, Ohno J, Suzuki M, Anno T, Sugino M, Nagata K. Higher C-reactive protein concentration and white blood cell count in subjects with more coronary risk factors and/or lower physical fitness among apparently healthy Japanese. Circ J 2002; 66: 677-684.
24. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
25. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913-919.
26. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106: 1439-1441.